Achieve Life Sciences Inc... (ACHV)
NASDAQ: ACHV
· Real-Time Price · USD
2.54
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:59 PM
2.46
-3.34%
After-hours: Aug 15, 2025, 07:49 PM EDT
Achieve Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -12.83M | -12.36M | -12.51M | -8.46M | -6.49M | -5.48M | -7.11M | -8.24M | -8.99M | -11.23M | -13.08M | -10.47M | -7.57M | -7.15M | -6.69M | -11.31M | -8M |
Depreciation & Amortization | 62K | 58K | 57K | 57K | 57K | 57K | 58K | 55K | 58K | 65K | 55K | 56K | 60K | 62K | 61K | 63K | 64K |
Stock-Based Compensation | 2.23M | 1.24M | 1.34M | 1.45M | 1.29M | -10K | 1.17M | 1.19M | 1.08M | 778K | 829K | 840K | 823K | 494K | 530K | 621K | 542K |
Other Working Capital | n/a | 467K | -1.3M | 1.33M | -536K | 117K | -275K | 607K | -157K | -2.31M | 827K | 725K | 37K | 1.35M | -2.83M | 1.54M | 665K |
Other Non-Cash Items | n/a | 464K | 1.58M | 1.92M | 2.07M | 1.15M | 738K | 413K | 300K | 307K | 303K | 289K | 297K | 1.46M | 563K | 18K | 23K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -152K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.46M | n/a | n/a | n/a |
Change in Working Capital | n/a | 1.41M | -835K | 1.5M | -670K | 69K | 2K | -95K | -754K | -1.06M | 583K | 963K | -386K | 1.38M | -2.59M | 1.53M | 918K |
Operating Cash Flow | -11.09M | -9.19M | -10.37M | -4.92M | -5.29M | -4.36M | -5.14M | -6.68M | -8.3M | -11.14M | -11.31M | -8.32M | -6.78M | -5.22M | -8.69M | -9.08M | -6.45M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -6K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -3.36M | -930K | -389K | -46.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 14.72M | 12.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 13.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 11.35M | 11.72M | 13.27M | -46.57M | n/a | -6K | -15K | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | -30K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 682K | -8.12M | -114K | n/a | 30K | n/a | -70K | 47K | n/a | 126K | -47K | 4K | 14.93M | 8K | 95K | 236K |
Financial Cash Flow | n/a | 682K | -8.11M | -153K | 56.11M | n/a | n/a | 15.23M | 47K | 17.71M | 126K | 1.36M | 95K | 14.93M | 8K | 21.44M | 236K |
Net Cash Flow | 263K | 3.21M | -5.21M | -51.64M | 50.85M | -4.37M | -5.15M | 8.56M | -8.26M | 6.57M | -11.18M | -6.96M | -6.68M | 9.71M | -8.69M | 12.36M | -6.22M |
Free Cash Flow | -11.09M | -9.19M | -10.37M | -4.92M | -5.29M | -4.37M | -5.15M | -6.68M | -8.3M | -11.14M | -11.31M | -8.32M | -6.78M | -5.22M | -8.69M | -9.08M | -6.45M |